Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05178290 · ClinicalTrials.gov registry record · NA

Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers

A NA study of Exercise and Diet, Healthy, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
1,356
Enrollment target
1
Study location

NCT05178290 is a NA study of Exercise and Diet, Healthy that has completed, run by Arizona State University. The registered enrollment target is 1,356 participants, below the 8,887-participant average among 57 other Exercise trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05178290, a NA study of Exercise and Diet, Healthy, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
1,356 participants
Enrollment target
1
Study location

Study Summary

This study aims to get children safely back to school by (1) Child and Family Testing, (2) ECE Personnel Testing, and (3) Outdoor Learning via Garden Education.

Interventions

  • BEHAVIORAL CHILD back-to-ECE COVID-19 saliva testing
  • BEHAVIORAL ECE personnel back-to-ECE COVID-19 saliva screening
  • BEHAVIORAL SAGE garden programming

Study Locations (1)

Arizona

  • Arizona State University-Downtown Campus - Phoenix

Trial Details

FieldValue
Enrollment Target 1,356 participants
Start Date 2021-11-22
Est. Completion 2023-06-30
Phase NA

Sponsor

Arizona State University

187 total trials

What the Registry Record Tells You About NCT05178290

The ClinicalTrials.gov registry entry for NCT05178290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,356 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,887-participant average among 57 other Exercise trials with a reported enrollment target (85% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Exercise appearing as the primary indexed condition, and to 3 interventions - of which CHILD back-to-ECE COVID-19 saliva testing is the first listed.

NCT05178290 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05178290 about?

NCT05178290 is a clinical study titled "Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers". This study aims to get children safely back to school by (1) Child and Family Testing, (2) ECE Personnel Testing, and (3) Outdoor Learning via Garden Education.

What is the current status of trial NCT05178290?

This trial is currently completed. It is a NA study. The enrollment target is 1,356 participants. The study started on 2021-11-22. Estimated completion is 2023-06-30.

What conditions does trial NCT05178290 study?

This clinical trial studies the following conditions: Exercise, Diet, Healthy, Child Development, Parents, Self-Control.

What interventions are being tested in trial NCT05178290?

The interventions under investigation include: CHILD back-to-ECE COVID-19 saliva testing (BEHAVIORAL), ECE personnel back-to-ECE COVID-19 saliva screening (BEHAVIORAL), SAGE garden programming (BEHAVIORAL).

Who is sponsoring clinical trial NCT05178290?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05178290 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.